<?xml version="1.0" encoding="UTF-8"?>
<p>From January to December of 2017, we collected a total of 328 nasopharyngeal swab samples (267 samples from Yangon study site and 61 samples from Pyinmana study site of Myanmar) from out-patients presenting influenza-like illness symptoms and 288 nasopharyngeal swab samples (from Yangon study site of Myanmar) from in-patients presenting acute respiratory tract infections, and tested the samples for the presence of influenza virus. Rapid test kit assay indicated that a total of 280 samples (45.5%) were positive for the influenza virus. All 616 nasopharyngeal swab samples were also screened by real-time PCR assay. Influenza A(H1N1)pdm09 viruses represented the majority of circulating influenza viruses during 2017 (233, 37.8%) (
 <xref rid="pone.0229601.t001" ref-type="table">Table 1</xref>).
</p>
